ChromaDex Partners with Longevity.Technology to Launch Niagen®-Infused Longevity Supplement
- ChromaDex's Niagen® is featured in Longevity.Technology's first supplement, promoting healthier aging through NAD+ enhancement.
- Over 30 clinical studies support Niagen’s benefits for cellular, brain, heart, and muscle health.
- The partnership emphasizes scientific integrity and transparency in developing effective aging solutions.
ChromaDex Launches Niagen® in Longevity Supplement Partnership
ChromaDex Corp. solidifies its position as a key player in the longevity and health optimization sector with the announcement that its flagship ingredient, Niagen®, is featured in Longevity.Technology’s first-ever supplement, Longevity.Technology® LONGEVITY. This new supplement is designed to promote healthier aging by leveraging Niagen's acclaimed ability to enhance levels of nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular health. With an increasing focus on age-related health solutions, this collaboration positions ChromaDex at the forefront of scientific advancements in the nutritional supplement industry.
Rob Fried, CEO of ChromaDex, underscores the significance of Niagen in the quest for effective and safe aging solutions. He cites the ingredient's proven efficiency as an NAD+ precursor, which is backed by over 30 peer-reviewed clinical studies. These studies highlight Niagen’s multifaceted health benefits, including support for cellular, brain, heart, and muscle health. The partnership with Longevity.Technology not only broadens the reach of Niagen but also enhances consumer access to scientifically validated products aimed at improving health outcomes as individuals age. This strategic move reflects ChromaDex’s commitment to making credible, evidence-based aging solutions widely available.
The LONGEVITY supplement is produced by ProTab Laboratories, known for its adherence to current Good Manufacturing Practices (cGMP), ensuring high standards for product quality and consistency. Dev Heaton, head of Longevity.Technology’s Consumer Division, emphasizes the necessity of evidence-based products in the longevity market, affirming that their collaboration with ChromaDex aligns with their mission to uphold rigorous scientific standards. With ChromaDex's robust intellectual property portfolio, featuring over 90 patents that safeguard Niagen and its derivatives, the company is poised to maintain its competitive edge in the evolving landscape of health and wellness products.
In addition to the launch of the LONGEVITY supplement, ChromaDex continues to enhance its reputation in the market through rigorous research and development. The company's proactive approach to innovation ensures that it remains at the forefront of advancements in NAD+ research and its applications for health. With growing consumer interest in longevity and wellness, ChromaDex’s strategic initiatives are likely to resonate well with health-conscious individuals seeking scientifically supported solutions.
As the demand for effective aging solutions rises, ChromaDex’s partnership with Longevity.Technology exemplifies a significant step forward in the integration of science and consumer health products. The collaboration not only highlights the efficacy of Niagen but also reinforces the importance of transparency and scientific integrity in the burgeoning longevity supplement sector.